Greenwich Lifesciences is engaged in the development of peptide immunotherapy for breast cancer, aiming to reduce the recurrence of breast cancer following surgery.
No data available
Are you interested in the impact of this company or this ETF?
It seems we haven't collected any data here yet. Just let us know and we will try to find data as soon as possible. Thank you for your feedback!